Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Utility of Systemic Staging in Low Grade B-Cell Lymphomas Presenting in the Skin

Meenal Kheterpal, MD, Shamir Geller, MD, Julia Dai, MD, Melissa Pulitzer, MD, Patricia Myskowski, MD, Alison J. Moskowitz, MD, Jinah Kim, MD PhD, Richard T. Hoppe, MD, Youn H. Kim, MD, Steven M. Horwitz, MD

Blood (2017) 130 (Supplement 1): 2774.

https://doi.org/10.1182/blood.V130.Suppl_1.2774.2774

Published: 2017

Journal Articles

ASN002: A Potent Dual SYK/JAK Inhibitor Currently in a Phase I/II Study Shows Strong Antitumor Activity in Preclinical Studies

Niranjan S. Rao, PhD, Sanjeeva Reddy, PhD, Gupta Sandeep, PhD, Nitin K Damle, PhD, Venkatesan M Aranapakam, PhD, Scott Thompson, PhD, Roger Smith, PhD, Terry Plasse, MD, Penelope Bristow, MS, Anthony Tolcher, MD, Kyriakos P Papadopoulos, MD, Amita Patnaik, MD, Drew W Rasco, MD

Blood (2015) 126 (23): 4009.

https://doi.org/10.1182/blood.V126.23.4009.4009

Published: 2015

Journal Articles

Autologous Stem Cell Transplantation Improves Survival For High Risk Cardiac Amyloidosis

Piyanuch Kongtim, MD, Muzaffar H. Qazilbash, MD, Jatin J. Shah, M.D., Robert Z. Orlowski, M.D., Ph.D., Amir Hamdi, MD, Nina Shah, MD, Qaiser Bashir, MD, Michael Wang, MD, Richard E Champlin, MD, Simrit Parmar, MD

Blood (2013) 122 (21): 3341.

https://doi.org/10.1182/blood.V122.21.3341.3341

Published: 2013

Journal Articles

Allogenic Transplantation in Lymphomas: A Focused Analysis On Aggressive Lymphomas and Factors Predictive of Outcome in a Series of 179 Pts Treated At John Theurer Cancer Center.

Anthony R Mato, MD, Kathryn Waksmundzki, BS, Tania Zielonka, RDC, Ewelina A Protomastro, BA, Theresa Amatucci, BS, Maria Rosario, Stuart L. Goldberg, MD, Tatyana Feldman, MD, Scott D Rowley, MD, Michele L. Donato, MD, Mary Timberg, RN, MSN, OCN, NP-C, Melissa F Baker, APN, Pam Sutherland, MSN, CRNP, Phyllis McKiernan, MSN, CRNP, Andrew L Pecora, MD, Andre Goy, MD

Blood (2012) 120 (21): 3120.

https://doi.org/10.1182/blood.V120.21.3120.3120

Published: 2012

Journal Articles

Feasibility and Outcome of High Dose Therapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma in the Geriatric Population

Anthony R Mato, MD, Andre Goy, MD, Kathryn Waksmundzki, BS, Tatyana Feldman, MD, Tania Zielonka, RDC, Ewelina A Protomastro, BA, Coleen Bejot, MSN, NP-C, Gabriella Gadaleta, RN, APN-C, Scott D Rowley, MD, Michele L Donato, MD, Andrew L Pecora, MD, Katherine Facchin, RN, John P. Leonard, MD, Richard R. Furman, MD, Jia Ruan, MD, PhD, Tsiporah B Shore, Usama Gergis, MD, Morton Coleman, MD, Rebecca Elstrom, MD

Blood (2012) 120 (21): 4269.

https://doi.org/10.1182/blood.V120.21.4269.4269

Published: 2012

Journal Articles

A Decade of Stem Cell Transplantation in Lymphoma: Single Center Experience and Outcome of 938 Consecutive Allogeneic and Autologous Hematopoietic Stem Cell Transplants Performed At John Theurer Cancer Center

Anthony R Mato, MD, Andrew L Pecora, MD, Scott D Rowley, MD, Michele L Donato, MD, Stuart L. Goldberg, MD, Tatyana Feldman, MD, David H. Vesole, MD, PhD, Tania Zielonka, Theresa Amatucci, Alexandria Campaiola, BSN, Arun K Singavi, BS, Clement Cousin, MBBS, Andre Goy, MD

Blood (2011) 118 (21): 3086.

https://doi.org/10.1182/blood.V118.21.3086.3086

Published: 2011

Journal Articles

Fludarabine, Cyclophosphamide and Lenalidomide (FCL) for Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL): Results of the Dose-Finding Phase of the GIMEMA LLC606 Study

Francesca Romana Mauro, MD, Daniele Armiento, MD, Sonia Orlando, BS, Ilaria Del Giudice, MD, Maria Stefania De Propriis, PhD, Mauro Nanni, PhD, Marilisa Marinelli, PhD, Molica Matteo, Paola Fazi, MD, Francesca Paoloni, BS, Graziosi Antonietta, Laura Collada, Anna Guarini, PhD, Robin Foà, MD

Blood (2010) 116 (21): 1377.

https://doi.org/10.1182/blood.V116.21.1377.1377

Published: 2010

Journal Articles

Pre-Transplant Rituximab Is Associated with Reduced Rate of Acute GvHD After RIC-Allosct In Lymphoma Patients: Results From A Retrospective Monocenter Analysis.

Roberto Crocchiolo, Jr, Jean El Cheikh, Luca Castagna, Alix Helvig, Sabine Furst, Catherine Faucher, Alberto Vazquez, Nawel Belmecheri, Angela Granata, Diane Coso, MD, Reda Bouadaballah, Didier Blaise, MD

Blood (2010) 116 (21): 1319.

https://doi.org/10.1182/blood.V116.21.1319.1319

Published: 2010

Journal Articles

Impact of Minor Histocompatibility Antigens (mHAg) Mismatches On Gvhd Incidence in Non-Myeloablative or Reduced Intensity Allogeneic Stem Cell Transplantation.

Cristiana Carniti, PhD, Francesco Spina, MD, Antonio Vendramin, PhD, Simona Di Terlizzi, Anna Raganato, PhD, Anisa Bermema, Paolo Corradini, MD

Blood (2009) 114 (22): 4494.

https://doi.org/10.1182/blood.V114.22.4494.4494

Published: 2009

Journal Articles

Pegylated Liposomal Doxorubicin, Bleomycin, Vinblastine and Dacarbazine (CBVD) in the Treatment of Advanced Primary Cutaneous Lymphomas.

Elisabetta Abruzzese, Massimiliano Postorino, md, phd, Tullio Faraggiana, MD, Daniela Renzi, Manuela Rizzo, Micol Quaresima, Livio Pupo, Roberta Cannarsa, Alessandra Spagnoli, Sara Vaccarini, Malgorzata Monika Trawinska, Lucia Anemona, Giuseppe Lombardo, Maria Cantonetti, MD

Blood (2009) 114 (22): 3717.

https://doi.org/10.1182/blood.V114.22.3717.3717

Published: 2009

Journal Articles

Abnormalities in Serum Free-Immunoglobulin Light Chains Show a High and Differential Frequency among WHO Subtypes of B-Cell Non-Hodgkin’s Lymphoma (NHL) and May Turn of Value for Therapeutic Monitoring: A Study of 354 Newly Diagnosed Patients

Antonio Pinto, MD, Rosaria De Filippi, MD, PhD, Giancarla Iaccarino, D.Sci, Raffaele Di Francia, D.Sci, Mariarosaria Distinto, D.Sci, Ferdinando Frigeri, MD, PhD, Filippo Russo, MD, Alessandro Marchei, D.Sci, Barbara Amoroso, MD

Blood (2008) 112 (11): 2813.

https://doi.org/10.1182/blood.V112.11.2813.2813

Published: 2008

Journal Articles

The Impact of Therapeutic Management and Prognostic Factors on the Outcome of Primary Cutaneous B-Cell Lymphomas (PCBCL) (IELSG 11 Study)

Blood (2008) 112 (11): 3608.

https://doi.org/10.1182/blood.V112.11.3608.3608

Published: 2008

Journal Articles

High Response Rate to Lenalidomide in Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma with Prior Stem Cell Transplant.

Julie M. Vose, MD, Joseph M. Tuscano, MD, Glen Justice, MD, Izidore S. Lossos, MD, Annette Ervin-Haynes, DO, Kenichi Takeshita, MD, Dennis Pietronigro, PhD, Jerome B. Zeldis, MD, PhD, Thomas M. Habermann, MD

Blood (2007) 110 (11): 2570.

https://doi.org/10.1182/blood.V110.11.2570.2570

Published: 2007

Journal Articles

The Brain Transcription Factor OTX1 Is Activated in Specific Non-Hodgkin Lymphoma Subtypes and Normally Expressed in a Germinal Center-Restricted Small Subpopulation of CD138 + Plasmacell-Like Cells.

Filippo Russo, MD, Daniela Omodei, Dario Acampora, Rosaria De Filippi, MD, Valeria Severino, Raffaele Di Francia, Ferdinando Frigeri, MD, Pietro Mancuso, Anna De Chiara, MD, Renato Franco, MD, Stefano Casola, Antonio Pinto, Antonio Simeone

Blood (2007) 110 (11): 2618.

https://doi.org/10.1182/blood.V110.11.2618.2618

Published: 2007

Journal Articles

Combined BIOMED-2 Clonality Assays for IGH and IGK and Assessment of t(14;18) on Formalin-Fixed, Paraffin Embedded Tissues Effectively Separates Primary Cutaneous B Cell Lymphomas from Reactive Cutaneous Lymphoid Hyperplasia.

Anjali V. Morales, MD, PhD, Katie Seo, MS, Daniel A. Arber, MD, Sabine Kohler, MD, Youn H. Kim, MD, Uma Sundram, MD

Blood (2007) 110 (11): 2623.

https://doi.org/10.1182/blood.V110.11.2623.2623

Published: 2007

Journal Articles

Results from a Phase II Study of Lenalidomide Oral Monotherapy in Relapsed/Refractory Indolent Non-Hodgkin’s Lymphoma.

Thomas E. Witzig, MD, Julie M. Vose, MD, Timothy D. Moore, MD, Craig B. Reeder, MD, Craig E. Cole, MD, Glen Justice, MD, Henry P. Kaplan, MD, Michael Voralia, MD, Dennis Pietronigro, PhD, Kenichi Takeshita, MD, Annette Ervin-Haynes, DO, Jerome B. Zeldis, MD, PhD, Peter H. Wiernik, MD

Blood (2007) 110 (11): 2560.

https://doi.org/10.1182/blood.V110.11.2560.2560

Published: 2007

Journal Articles

Lenalidomide Response in Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma Is Related to Tumor Burden and Time from Rituximab Treatment.

Peter H. Wiernik, MD, Izidore S. Lossos, MD, Joseph M. Tuscano, MD, Glen Justice, MD, Julie M. Vose, MD, Craig E. Cole, MD, Kyle McBride, MS, Kenton Wride, Dennis Pietronigro, PhD, Kenichi Takeshita, MD, Annette Ervin-Haynes, DO, Jerome B. Zeldis, MD, PhD, Thomas M. Habermann, MD

Blood (2007) 110 (11): 2565.

https://doi.org/10.1182/blood.V110.11.2565.2565

Published: 2007

Journal Articles

Non Hodgkin Lymphoma (NHL) Distribution and Clinical Characteristics in a Mexican Registry with High Frequency of T Cell NHL: A Descriptive Study on Behalf of Mexican Hematology Study Group (MHSG).

Gregorio Ignacio, MD, Francisco Tripp, MD, Petty Rodríguez, MD, Mario Martínez, MD, Concepción Martínez, MD, Elsa Ávila, MD, Severiano Baltazar, MD, Alva Zaragoza, MD, Silvia Rivas, MD, Eduardo E. Reynoso, MD

Blood (2007) 110 (11): 4407.

https://doi.org/10.1182/blood.V110.11.4407.4407

Published: 2007

Journal Articles

Preliminary Results from a Phase II Study of Lenalidomide Monotherapy in Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma.

Peter H. Wiernik, MD, Izidore Lossos, MD, Joseph Tuscano, MD, Glen Justice, MD, Julie M. Vose, MD, Dennis Pietronigro, PhD, Kenichi Takeshita, MD, Annette Ervin-Haynes, DO, Jerome B. Zeldis, MD,PhD, Thomas M. Habermann, MD

Blood (2006) 108 (11): 531.

https://doi.org/10.1182/blood.V108.11.531.531

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma: Data from National Czech Registry.

Veronika Valkova, Antonin Vitek, Edgar Faber, Jiri Mayer, Pavel Zak, Katerina Benesova, Marek Trneny

Blood (2006) 108 (11): 5375.

https://doi.org/10.1182/blood.V108.11.5375.5375

Published: 2006

NARROW

Utility of Systemic Staging in Low Grade B-Cell Lymphomas Presenting in the Skin

ASN002: A Potent Dual SYK/JAK Inhibitor Currently in a Phase I/II Study Shows Strong Antitumor Activity in Preclinical Studies

Autologous Stem Cell Transplantation Improves Survival For High Risk Cardiac Amyloidosis

Allogenic Transplantation in Lymphomas: A Focused Analysis On Aggressive Lymphomas and Factors Predictive of Outcome in a Series of 179 Pts Treated At John Theurer Cancer Center.

Feasibility and Outcome of High Dose Therapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma in the Geriatric Population

A Decade of Stem Cell Transplantation in Lymphoma: Single Center Experience and Outcome of 938 Consecutive Allogeneic and Autologous Hematopoietic Stem Cell Transplants Performed At John Theurer Cancer Center

Fludarabine, Cyclophosphamide and Lenalidomide (FCL) for Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL): Results of the Dose-Finding Phase of the GIMEMA LLC606 Study

Pre-Transplant Rituximab Is Associated with Reduced Rate of Acute GvHD After RIC-Allosct In Lymphoma Patients: Results From A Retrospective Monocenter Analysis.

Impact of Minor Histocompatibility Antigens (mHAg) Mismatches On Gvhd Incidence in Non-Myeloablative or Reduced Intensity Allogeneic Stem Cell Transplantation.

Pegylated Liposomal Doxorubicin, Bleomycin, Vinblastine and Dacarbazine (CBVD) in the Treatment of Advanced Primary Cutaneous Lymphomas.

Abnormalities in Serum Free-Immunoglobulin Light Chains Show a High and Differential Frequency among WHO Subtypes of B-Cell Non-Hodgkin’s Lymphoma (NHL) and May Turn of Value for Therapeutic Monitoring: A Study of 354 Newly Diagnosed Patients

The Impact of Therapeutic Management and Prognostic Factors on the Outcome of Primary Cutaneous B-Cell Lymphomas (PCBCL) (IELSG 11 Study)

High Response Rate to Lenalidomide in Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma with Prior Stem Cell Transplant.

The Brain Transcription Factor OTX1 Is Activated in Specific Non-Hodgkin Lymphoma Subtypes and Normally Expressed in a Germinal Center-Restricted Small Subpopulation of CD138 + Plasmacell-Like Cells.

Combined BIOMED-2 Clonality Assays for IGH and IGK and Assessment of t(14;18) on Formalin-Fixed, Paraffin Embedded Tissues Effectively Separates Primary Cutaneous B Cell Lymphomas from Reactive Cutaneous Lymphoid Hyperplasia.

Results from a Phase II Study of Lenalidomide Oral Monotherapy in Relapsed/Refractory Indolent Non-Hodgkin’s Lymphoma.

Lenalidomide Response in Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma Is Related to Tumor Burden and Time from Rituximab Treatment.

Non Hodgkin Lymphoma (NHL) Distribution and Clinical Characteristics in a Mexican Registry with High Frequency of T Cell NHL: A Descriptive Study on Behalf of Mexican Hematology Study Group (MHSG).

Preliminary Results from a Phase II Study of Lenalidomide Monotherapy in Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma.

Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma: Data from National Czech Registry.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only